Glycemic control and cardiovascular disease--should we reassess clinical goals?
暂无分享,去创建一个
[1] E. Barrett-Connor,et al. GHb Is a Better Predictor of Cardiovascular Disease Than Fasting or Postchallenge Plasma Glucose in Women Without Diabetes: The Rancho Bernardo Study , 1996, Diabetes Care.
[2] Colin Mathers,et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. , 2005, Diabetes care.
[3] N. Wareham,et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) , 2001, BMJ : British Medical Journal.
[4] Neil R. Powe,et al. Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.
[5] L. Bouter,et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study , 1999, Diabetologia.
[6] K. Dahl-Jørgensen,et al. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment? , 2005, Diabetologia.
[7] H. Keen,et al. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.
[8] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[9] Leiv Sandvik,et al. Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. , 2002, Diabetes.
[10] W. Tamborlane,et al. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. , 1999, Diabetes care.